Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity
AssigneeNovozymes A/S
InventorsHeinz-Josef Deussen, Arne Agerlin Olsen, Tine Muxoll Fatum, Erwin Ludo Roggen
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovozymes A/S
InventorsHeinz-Josef Deussen, Arne Agerlin Olsen, Tine Muxoll Fatum, Erwin Ludo Roggen
Estimating the term…
A polypeptide-polymer conjugate is prepared having one or more polymers covalently bound to a polypeptide. The polymer has the general formula; EOXPOY wherein EO is ethylene oxide, PO is propylene oxide, x=1−99%, y=1−99%, x+y=100%, and x and y are in a ratio range of 10:90 to 90:10, more preferably 40:60 to 60:40, or in a 50/50 ratio. The polymer, which can be a block polymer, typically has a molecular weight in a range of 100 to 100,000 daltons, and the polypeptide may contain 1 to 100 polymer molecules. Coupling the polypeptide, in particular enzymes, to the polymer reduces respiratory allergenicity of the polypeptide. Industrial compositions such as detergent compositions, personal care compositions, compositions for processing/treating textiles, and food and feed compositions containing the polypeptide-polymer conjugate have reduced respiratory allergenicity.
A polypeptide-polymer conjugate comprising a polypeptide covalently bound to one or more activated polymers, wherein the polymer is of formula I:
A method for reducing the respiratory allergenicity of a polypeptide, said method comprising covalently binding to the polypeptide one or more polymers of formula I:
Dependencies are inferred from the claim text.